Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Trial to Assess Clinical Utility and Effectiveness of MyOme's Polygenic Risk Score for Coronary Artery Disease (COMPASS-CAD)

NCT06542432 is registered in ClinicalTrials.gov with MyOme as lead sponsor.

NCT NCT06542432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06542432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Trial to Assess Clinical Utility and Effectiveness of MyOme's Polygenic Risk Score for Coronary Artery Disease (COMPASS-CAD)
Lead sponsor
MyOme
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
January 1, 2025
Completion date
July 1, 2029
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, coronary artery disease, coronary disease, heart diseases, myocardial infarction, polygenic risk score